Nmda-Receptor 发表于 2025-3-25 06:37:55

Submitted on: 28 June 1999.
Revised on: 18 July 1999.
Accepted on: 11 August 1999.
Therapeutic Advances in Drug Safety

Counteract 发表于 2025-3-25 10:09:29

Submitted on: 24 June 2005.
Revised on: 09 July 2005.
Accepted on: 06 August 2005.
Therapeutic Advances in Drug Safety

calumniate 发表于 2025-3-25 12:12:30

Submitted on: 22 September 2003.
Revised on: 07 October 2003.
Accepted on: 22 October 2003.
Therapeutic Advances in Drug Safety

Mangle 发表于 2025-3-25 16:39:45

http://reply.papertrans.cn/3/295/29437/29437-24.png

尾随 发表于 2025-3-25 21:54:10

Submitted on: 13 November 2005.
Revised on: 18 December 2005.
Accepted on: 09 January 2006.
Therapeutic Advances in Drug Safety

evaculate 发表于 2025-3-26 03:16:00

http://reply.papertrans.cn/3/295/29437/29437-26.png

分开如此和谐 发表于 2025-3-26 06:59:37

Submitted on: 25 May 1998.
Revised on: 30 June 1998.
Accepted on: 06 July 1998.
Therapeutic Advances in Drug Safety

ingestion 发表于 2025-3-26 11:15:36

Submitted on: 05 February 2003.
Revised on: 16 March 2003.
Accepted on: 05 April 2003.
Therapeutic Advances in Drug Safety

过度 发表于 2025-3-26 14:40:34

Submitted on: 26 December 2012.
Revised on: 28 January 2013.
Accepted on: 25 February 2013.
Therapeutic Advances in Drug Safety

Host142 发表于 2025-3-26 17:40:22

http://reply.papertrans.cn/3/295/29437/29437-30.png
页: 1 2 [3] 4
查看完整版本: SCIE期刊Therapeutic Advances in Drug Safety 2024/2025影响因子:3.459 (THER ADV DRUG SAF) (2042-0986). (PHARMACOLOGY & PHARMACY